VMAT技术在NSCLC放射治疗中的剂量学参数研究
Study on dosimetric parameters of VMAT in radiotherapy for NSCLC
投稿时间:2026-06-25  修订日期:2026-08-18
DOI:
中文关键词:  非小细胞肺癌  容积旋转调强放疗  剂量学参数
英文关键词:Non-small cell lung cancer  Volumetric modulated arc therapy  Dosimetry parameter
基金项目:
作者单位邮编
张婧 广西医科大学附属肿瘤医院 530021
梁育林 广西医科大学附属肿瘤医院 
林宏彦 广西医科大学附属肿瘤医院 
胡秀琼* 广西医科大学附属肿瘤医院 530021
摘要点击次数: 37
全文下载次数: 12
中文摘要:
      [目的] 探讨容积旋转调强放疗(VMAT)技术在非小细胞肺癌(NSCLC)放射治疗中的剂量学参数。[方法] 选取我院2023年1月~2025年1月收治的60例局部NSCLC患者作为研究对象,在同一套CT及同一套靶区下使用同一套计划系统以及同一型号加速器分别设计IMRT、VMAT两个计划,IMRT计划采用Step & Shoot IMRT技术,VMAT计划采用VMAT技术,比较两组计划总跳数、治疗时间、靶区以及危及器官剂量学参数。[结果] 相较于IMRT技术治疗时间(7.23±1.50)min,VMAT技术治疗时间(4.62±0.89)min更短(t=11.591,P<0.05);两组计划总跳数比较无较大差异(P>0.05)。VMAT计划靶区(PTV)的D98(55.86±0.97)Gy、D2(62.05±1.12)Gy、Dmean(59.39±0.65)Gy、均匀性指数(HI)(0.12±0.03)、适形指数(CI)(0.88±0.05)水平比IMRT计划靶区PTV的D98(54.63±0.81)Gy、D2(61.35±1.17)Gy、Dmean(59.13±0.75)Gy、HI(0.08±0.03)、CI(0.83±0.06)水平更高(t=7.539;t=3.348;t=2.029;t=7.303;t=4.959,P<0.05),肺(V30、V20、V5、MLD)、脊髓(Dmax)水平更低(t=3.060;t=3.075;t=10.433;t=4.096;t=2.811,P<0.05)。两组计划心脏(V45、V40、V30、MHD)、食管(V45、Dmax、MED)、脊髓(Dmean)剂量学参数均相近(P=0.106~0.729)。中央型NSCLC患者中,VAMT计划PTV的CI(0.84±0.05)、肺(V5)(44.37±7.12)%高于IMRT计划PTV的CI(0.74±0.03)、肺(V5)(38.46±7.04)%(t=8.044;t=2.768;P<0.05),周围型NSCLC患者中,VMAT计划PTV的CI(0.81±0.08)高于IMRT计划的CI(0.72±0.05)(t=4.475;P<0.05)。[结论] 相较于IMRT技术,VMAT技术治疗NSCLC可在提高靶区剂量的基础上减少对周围肺组织的剂量。
英文摘要:
      [Objective] To explore dosimetric parameters of volumetric modulated arc therapy (VMAT) in radiotherapy for non-small cell lung cancer (NSCLC). [Methods] A total of 60 patients with local NSCLC admitted to the hospital were enrolled between January 2023 and January 2025. Two plans [intensity modulated radiotherapy (IMRT), VMAT] were designed by the same planning system and the same accelerator under the same set of CT and target volume. Step & Shoot IMRT technique was applied in IMRT plan, while VMAT technique was applied in VMAT plan. Total monitor units, treatment time, dosimetric parameters of target volume and organs at risk in the two plans were compared. [Results] Compared with the duration of IMRT [(7.23±1.50) min], the duration of VMAT [(4.62±0.89) min] was shorter (t=11.591, P<0.05). There was no significant difference in total monitor units between the two plans (P>0.05). D98, D2, Dmean, homogeneity index (HI) and conformity index (CI) of planning target volume (PTV) in VMAT plan [(55.86±0.97) Gy, (62.05±1.12) Gy, (59.39±0.65) Gy, (0.12±0.03) and (0.88±0.05)] were higher than those in IMRT plan [(54.63±0.81) Gy, (61.35±1.17) Gy, (59.13±0.75) Gy, (0.08±0.03) and (0.83±0.06)] (t=7.539, 3.348, 2.029, 7.303, 4.959, P<0.05). Lung V30, V20, V5 and MLD, and spinal cord Dmax in VMAT plan were lower (t=3.060, 3.075, 10.433, 4.096, 2.811, P<0.05). Dosimetric parameters of the heart (V45, V40, V30, MHD), esophagus (V45, Dmax, MED), and spinal cord Dmean were comparable between the two plans (P=0.106-0.729). In patients with central NSCLC, CI and lung V5 in VMAT plan [(0.84±0.05) and (44.37±7.12)%] were higher than those in IMRT plan [(0.74±0.03) and (38.46±7.04)%] (t=8.044, 2.768, P<0.05). In patients with peripheral NSCLC, CI in VMAT plan (0.81±0.08) was higher than that in IMRT plan (0.72±0.05) (t=4.475, P<0.05). [Conclusion] Compared with IMRT, VMAT can reduce dose to surrounding lung tissues while increasing target dose in NSCLC.
在线阅读     查看/发表评论  下载PDF阅读器